NCT02291289 2024-05-06
MODUL
Hoffmann-La Roche
Phase 2 Completed
Clinical Trials
4 trialsNCT02164916 2020-12-30
S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00405587 2017-08-22
Safety Study of PLX4032 in Patients With Solid Tumors
Plexxikon
Phase 1 Completed
NCT01791309 2016-01-05
Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed